Skip to main content

Advertisement

SpringerLink
Log in

The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer

  • Original Article
  • Published:
Esophagus Aims and scope Submit manuscript

Abstract

Background

Sarcopenia is defined by low muscle mass and low muscle strength and is a prognostic factor of unfavorable outcomes in various diseases. The purpose of this study is to examine the correlation between skeletal muscle wasting (SMW) during neoadjuvant chemotherapy (NAC) and postoperative complications in patients with esophageal cancer, particularly in relation to anastomotic leakage.

Methods

The present study involved 99 patients with thoracic esophageal cancer and esophago-gastric junctional cancer who received NAC followed by radical esophagectomy between August 2008 to June 2019, and who were pStage 0–III. Patient demographics and clinical variables were retrospectively reviewed. For assessing the extent of SMW, the rate of change in skeletal muscle mass index (SMI) was measured from CT images at the level of the third lumbar vertebra. Factors associated with postoperative complications were also examined.

Results

The median rate of change in total SMI in patients was − 1.87%. The decreased rates in SMI of the side abdominal muscles and rectus abdominis were significantly greater than that of the psoas major (side abdominal muscles: p = 0.0084, rectus abdominis: p = 0.036). Multivariate analysis showed a decreased rate in SMI, especially in the erector spinae muscle, and the Charlson comorbidity index (CCI) was significantly associated with Grade IIIa of higher anastomotic leakage (Grade ≥ IIIa) (SMI cutoff (favorable): ≤ − 7.84, p = 0.0040; CCI cutoff (favorable): ≥ 2, p = 0.0032).

Conclusion

In patients with esophageal cancer, SMI tend to decrease during NAC treatment. It is therefore important to prevent the additional impact that SMW during NAC has on postoperative anastomotic leakage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Takeda K, Umezawa R, Takahashi N, et al. Impact of change in serum albumin level during and after chemoradiotherapy in patients with locally advanced esophageal cancer. Esophagus. 2018;15:190–7.

    Article  Google Scholar 

  2. Yin LX, Chen BM, Zhao GF, et al. Scoring system to predict the risk of surgical site infection in patients with esophageal cancer after esophagectomy with cervical anastomosis. Surg Infect (Larchmt). 2018;19:696–703.

    Article  Google Scholar 

  3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39:412–23.

    Article  Google Scholar 

  4. Harada K, Ida S, Baba Y, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2016;29:627–33.

    Article  CAS  Google Scholar 

  5. Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266:822–30.

    Article  Google Scholar 

  6. Yohei O, Toru N, Yusuke T, et al. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy. Esophagus. 2019;16:345–51.

    Article  Google Scholar 

  7. Begini P, Gigante E, Antonelli G, et al. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis. Ann Hepatol. 2017;16:107–14.

    Article  Google Scholar 

  8. Ninomiya G, Fujii T, Yamada S, Yabusaki N, et al. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: a retrospective cohort study. Int J Surg. 2017;39:45–51.

    Article  Google Scholar 

  9. Anker SD, Coats AJ, Morley JE, et al. Muscle wasting disease: a proposal for a new disease classification. J Cachexia Sarcopenia Muscle. 2014;5:1–3.

    Article  Google Scholar 

  10. Ando N, Kato H, Igaki H, Shinoda M, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.

    Article  Google Scholar 

  11. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.

    Article  Google Scholar 

  12. Ida S, Watanabe M, Karashima R, et al. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol. 2014;21:3675–9.

    Article  Google Scholar 

  13. Schizas D, Frountzas M, Lidoriki I, et al. Sarcopenia does not affect postoperative complication rates in oesophageal cancer surgery: a systematic review and meta-analysis. Ann R Coll Surg Engl. 2019;11:1–13.

    Article  Google Scholar 

  14. Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25–43.

    Article  Google Scholar 

  15. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.

    Article  Google Scholar 

  16. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5.

    CAS  PubMed  Google Scholar 

  17. Martin L, Lagergren J, Lindblad M, et al. Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg. 2007;94:1496–500.

    Article  CAS  Google Scholar 

  18. Backemar L, Lagergren P, Djärv T, et al. Comorbidities and risk of complications after surgery for esophageal cancer: a Nationwide Cohort Study in Sweden. World J Surg. 2015;39:2282–8.

    Article  Google Scholar 

  19. Gronnier C, Tréchot B, Duhamel A, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg. 2014;260:761–4.

    Article  Google Scholar 

  20. Michelet P, D'Journo X-B, Roch A, et al. Perioperative risk factors for anastomotic leakage after esophagectomy: influence of thoracic epidural analgesia. Chest. 2005;128:3461–6.

    Article  Google Scholar 

  21. Wang Y, Yuqi M, Mingjian L, et al. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis. Cancer Commun (Lond). 2018;38:14.

    Article  Google Scholar 

  22. Kassis ES, Kosinski AS, Ross PJ, et al. Predictors of anastomotic leak after esophagectomy: an analysis of the Society of Thoracic Surgeons General Thoracic Database. Ann Thorac Surg. 2013;96:1919–26.

    Article  Google Scholar 

  23. Ercan S, Rice TW, Murthy SC, et al. Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg. 2005;129:623–31.

    Article  Google Scholar 

  24. Sugimura K, Miyata H, Matsunaga T, et al. Comparison of the modified Collard and hand-sewn anastomosis for cervical esophagogastric anastomosis after esophagectomy in esophageal cancer patients: a propensity score-matched analysis. Ann Gastroenterol Surg. 2018;3:104–13.

    Article  Google Scholar 

  25. Haverkamp L, van der Sluis PC, Verhage RJJ, et al. End-to-end cervical esophagogastric anastomoses are associated with a higher number of strictures compared with end-to-side anastomoses. J Gastrointest Surg. 2013;17:872–6.

    Article  Google Scholar 

  26. Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152–7.

    Article  Google Scholar 

  27. Saeterbakken AH, Fimland MS. Muscle activity of the core during bilateral, unilateral, seated and standing resistance exercise. Eur J Appl Physiol. 2012;112:1671–8.

    Article  Google Scholar 

  28. Callaghan JP, McGill SM. Low back joint loading and kinematics during standing and unsupported sitting. Ergonomics. 2001;44:280–94.

    Article  CAS  Google Scholar 

  29. Kippers V, Parker AW. Electromyographic studies of erectors spinae: symmetrical postures and sagittal trunk motion. Aust J Physiother. 1985;31:95–105.

    Article  CAS  Google Scholar 

  30. Standring S, editor. Gray’s anatomy: the anatomical basis of clinical practice. London: Churchill Livingstone; 2008.

    Google Scholar 

  31. Yoshio M, Murakami G, Sato T, et al. The function of the psoas major muscle: passive kinetics and morphological studies using donated cadavers. J Orthop Sci. 2002;7:199–207.

    Article  Google Scholar 

  32. Belavý DL, Armbrecht G, Richardson CA, et al. Muscle atrophy and changes in spinal morphology: is the lumbar spine vulnerable after prolonged bed-rest? Spine (Phila Pa 1976). 2011;36:137–45.

    Article  Google Scholar 

  33. Tanimura K, Sato S, Sato A, et al. Accelerated loss of antigravity muscles is associated with mortality in patients with COPD. Respiration. 2020;99:298–306.

    Article  Google Scholar 

  34. Akiko N, Hirotsugu O, Hiroyuki T, et al. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis. Sci Rep. 2020;11:2312.

    Google Scholar 

  35. Read JA, Beale PJ, Volker DH, et al. Nutrition intervention using an eicosapentaenoic acid (EPA) containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial. Support Care Cancer. 2007;15:301–7.

    Article  Google Scholar 

  36. Gonçalves Dias MC, de Fátima NMM, et al. Nutritional intervention improves the caloric and proteic ingestion of head and neck cancer patients under radiotherapy. Nutr Hosp. 2005;20:320–5.

    PubMed  Google Scholar 

  37. Vikberg S, Sörlén N, Brandén L, et al. Effects of resistance training on functional strength and muscle mass in 70-year-old individuals with pre-sarcopenia: a randomized controlled trial. J Am Med Dir Assoc. 2019;20:28–34.

    Article  Google Scholar 

  38. Pedersen BK, Akerstrom TC, Nielsen AR, et al. Role of myokines in exercise and metabolism. J Appl Physiol. 2007;103:1093–8.

    Article  CAS  Google Scholar 

  39. Pedersen BK, Fischer CP. Beneficial health effects of exercise–the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28:152–6.

    Article  CAS  Google Scholar 

  40. Adams GR. Autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol. 2001;93:1159–67.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, 1 Kawasumi, Mizuho-ku, Nagoya, Aichi, Japan

    Shiro Fujihata, Ryo Ogawa, Seiichi Nakaya, Shunsuke Hayakawa, Tomotaka Okubo, Hiroyuki Sagawa, Tatsuya Tanaka, Hiroki Takahashi, Yoichi Matsuo & Shuji Takiguchi

Authors
  1. Shiro Fujihata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryo Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seiichi Nakaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shunsuke Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomotaka Okubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroyuki Sagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tatsuya Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yoichi Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shuji Takiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shiro Fujihata.

Ethics declarations

Ethical statement

All procedures of this study were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fujihata, S., Ogawa, R., Nakaya, S. et al. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer. Esophagus 18, 258–266 (2021). https://doi.org/10.1007/s10388-020-00774-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10388-020-00774-1

Keywords

Search

Navigation